PARP inhibitors and epithelial ovarian cancer: an approach to targeted chemotherapy and personalised medicine. (Q37829771)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 January 2011

edit

Language	Label	Description	Also known as
English	PARP inhibitors and epithelial ovarian cancer: an approach to targeted chemotherapy and personalised medicine.	scientific article published on 18 January 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

PARP inhibitors and epithelial ovarian cancer: an approach to targeted chemotherapy and personalised medicine (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

main subject

ovarian cancer

1 reference

based on heuristic

inferred from title

chemotherapy

1 reference

based on heuristic

inferred from title

author

Nicola Curtin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

author name string

A Mukhopadhyay

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

R Plummer

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

R J Edmondson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

publication date

18 January 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

published in

BJOG: an International Journal of Obstetrics and Gynaecology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

volume

118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

page(s)

429-432

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

cites work

Cancer statistics, 2008

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

New targets for cancer chemotherapy--poly(ADP-ribosylation) processing and polyisoprene metabolism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

PARP inhibitors: will the new class of drugs match the hype?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Efficient Deletion of NormalBrca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2010.02838.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1471-0528.2010.02838.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

PubMed publication ID

21244617

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21244617

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244617%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

ResearchGate publication ID

49764609

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37829771&oldid=1416089061"